Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Authors
» Mark McCarty
Mark McCarty
Articles
ARTICLES
FDA to roll out 'track-and-trace' for drugs; devices may follow
July 12, 2006
By
Mark McCarty
Internet seen as conduit for best-practices dissemination
July 11, 2006
By
Mark McCarty
Panel: U.S. universal coverage will come with less med-tech
July 10, 2006
By
Mark McCarty
HSAs: fairly traditional coverage – or 'extra dollars for the rich'?
July 6, 2006
By
Mark McCarty
Moratorium on Medicare cuts for imaging eyed in H.R. 5704
July 6, 2006
By
Mark McCarty
New FDA guidances aimed at reducing 'gridlock' of trials
July 5, 2006
By
Mark McCarty
Risk analysis role in ICD implantation decision is debated
July 1, 2006
By
Mark McCarty
HSAs: fairly traditional coverage – or 'extra dollars for the rich'?
June 30, 2006
By
Mark McCarty
FDA's Tillman says product lifecycle model is 'outdated'
June 29, 2006
By
Mark McCarty
Hearing debates U.S. potential as payer for medical tourism
June 28, 2006
By
Mark McCarty
View All Articles by Mark McCarty
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe